PPARγ is a critical modulator against cardiac hypertrophy (25–27), and its agonists have been found to inhibit cardiomyocytes hypertrophy by improving metabolic homeostasis and inflammatory response (28). The gene discussed is PPARG; the disease is cardiac hypertrophy.